TAIPEI: Chinese vaccine company Sinovac announced Monday that it is planning to complete a new facility to double its annual vaccine production capacity to 600 million doses by the end of the year, while also securing a USD 500 million investment in a boost to its COVID-19 vaccine development efforts.The company is currently conducting the last stage of clinical trials for its vaccine candidate in Brazil, Turkey and Indonesia and is among the frontrunners of China’ s vaccine efforts. China has at least five COVID-19 vaccine candidates running late stage clinical trials across more than a dozen countries.Sino Biopharmaceutical Ltd., a pharmaceutical conglomerate, bought a 15 per cent stake in Sinovac for an investment of USD 500 million.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Withheld some a/cs within India, to continue advocating right of free expression: Twitter
New generation ICD with latest technology implanted at SSH Jammu
Arthritis drug no better than standard care for severe COVID-19, says study
People shouldn’t hesitate to get vaccinated, listen to scientists: Delhi’s 1st COVID patient
Gold tumbles Rs 522, silver crashes Rs 1,822
PNB Housing Finance, Yes Bank sign strategic co-lending pact for retail home loans
Rupee slumps 16 paise to 72.99 against US dollar in early trade
China fixes over 6 per cent as target for GDP in 2021
Rupee slumps 29 paise to 73.76 against US dollar in early trade
Download 10Cric Casino app, and enjoy Indias most popular casino games, directly on your mobile!
Gamble with real money online! Play Indias favourite casino games at 7Jackpots.com, Indias most trusted online casino site.
© 2020 State Times Daily Newspaper | Powered by Ideogram Technology Solutions [P] Ltd.